Background: Induced premature menopause and cardio-toxic therapy increase cardiovascular disease risk in female cancer survivors. Objective: To compare the effects of a 12 month aerobic-resistance fitness center intervention to home based physical activity on cardiovascular function and metabolic risk factors. Methods: Subjects (N ¼ 154) who had completed primary and/or adjuvant chemotherapy (past 3 years) were randomized to a fitness center intervention or a home based group. The fitness center intervention was a structured thrice weekly aerobic (30 min brisk walking treadmill in target heart range) combined with resistance (30 min of lower body strength training) exercise program, supervised for the first 6 months. The home based group received national guidelines for 30 min moderate intensity exercise most days of the week. Fasting serum samples were collected at baseline, 6 and 12 months for insulin, glucose, lipids and hemoglobin A-1C. A graded exercise stress test was also performed at baseline and 6 months. Results: The majority of subjects were white (85.7%), had breast cancer (83.1%) and the average age was 51.9 years. Subjects in the fitness center intervention had significantly improved time on treadmill (p ¼ .039), improved heart rate recovery at 1 min (p ¼ .028), greater MET minutes/week (p .0001), a trend for improved insulin resistance (p ¼ .067) and stable insulin levels (p ¼ .045) compared to the home based physical activity group. Conclusions: Exercise represents a potential cardiac risk reduction intervention for cancer survivors. Clinical Trials.gov: NCT01102985.
Introduction
Cancer and cardiovascular disease are integrally related and the growing specialty of cardio-oncology has identified the need for interdisciplinary collaboration in clinical care and research. 1, 2 The menopausal transition increases cardiovascular disease risk. 3 For women diagnosed with breast cancer, the known presence of cardiovascular risk factors (e.g. overweight, obesity, sedentary behavior), premature treatment induced menopause, cardiotoxicity associated with chemotherapy and targeted agents, deconditioning during treatment and aromatase inhibitor endocrine therapy have resulted in lower cardiovascular reserve and a predicted increased risk for cardiovascular disease. 4e8 There are more than 3 million breast cancer survivors and due to advances in breast cancer treatment, all-cause mortality has now surpassed breast cancer specific mortality. 9 Assessment of risk factors and risk reduction interventions are urgently needed. As one example, weight gain during and after breast cancer treatment is common, 10e12 which is associated with an increased risk of recurrence and lower survival 13e16 and represents a modifiable risk factor for tertiary prevention. 17, 18 Healthy lifestyle behaviors are recognized as essential risk reduction interventions for cardiovascular health in women. 1, 19, 20 Exercise has been shown to stabilize or prevent weight gain in healthy women 21 improves insulin resistance, 22 decreases the risk of diabetes 23 improves lipid profile 24, 25 and reduces overall cardiovascular disease risk. 26 For cancer survivors, physical activity has been shown to improve aerobic capacity, quality of life, strength, fatigue and depression, although there are wide variations in the exercise protocols in terms of duration, intensity, and types of delivery. 27e31 The increased risk of cardiovascular disease among breast cancer survivors due to aging, presence of cardiovascular risk factors and/or cardiotoxicity from cancer treatment 32e34 in the context of prolonged cancer survival rates supports an ongoing need to evaluate lifestyle behaviors as a cardiovascular risk reduction strategy. The purpose of the Yale Fitness Intervention Trial (Yale FIT), a randomized controlled trial (RCT), was to determine the effect of a 12-month aerobic-resistance exercise intervention compared to a home based physical activity group on cardiovascular function and metabolic risk factors in female cancer survivors. The hypothesis of the trial was that the aerobic-resistance exercise intervention would have significantly improved cardiovascular fitness outcomes and a better metabolic profile compared to the home based physical activity group at 6 and 12 months.
Methods

Subject recruitment
Subject recruitment, enrollment, attrition and intervention design has been previously described in detail. 35 Briefly, eligible subjects (breast, colorectal, gynecologic cancer or lymphoma diagnosis; 3 years since completion of non-endocrine cancer therapy; menopausal [peri or early postmenopausal, the latter defined as 5 years since last menstrual period], no resistance exercise ! 3 times/week; physically able to participate [physician permission]) were recruited predominantly from two hospital tumor registries supplemented by physician or self referrals from clinical sites. After baseline data were collected, we used a stratified randomization of blocks of 6 to help control the wave enrollment. We also stratified based on cancer site, as most subjects were expected to have a diagnosis of breast cancer. The study was approved by the Yale University Human Subjects Review Committee.
Exercise intervention protocol
The exercise intervention was an aerobic-resistance intervention delivered by trained research interventionists at community fitness centers (matched to where women lived or worked) 3 times per week, supervised for the first 6 months and unsupervised the last 6 months. The first 4 weeks were designed as progressive training to achieve the intervention target of 30 min of aerobic activity in the subject's target heart rate goal (65%e75%) through brisk walking on a treadmill and approximately 30 min of lower body resistance exercises including lunges, squats and 8 repetitions, specifically with leg press, toe press, leg extension, leg curl up and bent knee sit ups. The BORG Rating of Perceived Exertion Scale 36 was reviewed with subjects on beta blockers with the goal by the end of the four week training to have subjects exercising at 13e16 perceived exertion rating. Warm up and cool down stretching exercises were performed before and at the end of each exercise session. Subjects were encouraged to perform aerobic activity on other days of the week. For the subjects randomized to the home based group, national guidelines for physical activity for adults (30 min moderate level activity most days of the week) were provided and reviewed, supported by the American Cancer Society's "Smart Steps" booklet which describes examples of moderate intensity activities. Both the intervention and home-based groups received the American Cancer Society Nutrition Guidelines for cancer survivors. 37 
Metabolic data acquisition
Data were collected at the Yale Center for Clinical Investigation's Hospital Research Unit (HRU) at baseline, 6 and 12 months in the morning after a 12 h fast. Serum was collected for insulin, glucose, Hemoglobin A1-C, total cholesterol, triglycerides, and high density and low density lipoprotein. Insulin resistance was determined by the homeostatic model of assessment (HOMA) index (fasting plasma glucose [in millimoles per liter] X fasting plasma insulin [in microunits per millimeter] divided by 22.5). 38 Weight was recorded on a balance beam scale with light clothing and no shoes to the nearest pound and height measured to the nearest inch.
Hemodynamic monitoring and exercise testing
The study research nurse took blood pressure after a 10 min period of complete rest (supine) with a mercury sphygmomanometer. The mean of three resting BP readings taken 1 min apart was used as the resting blood pressure reading. A graded exercise treadmill test was performed at the Yale New Haven Hospital, Cardiovascular Nuclear Imaging and Exercise Laboratory at baseline and 6 months using a standard modified Bruce protocol with progressive 3 min stages of exercise. 39 A modified twelve lead electrocardiogram was obtained prior to exercise and recorded continuously throughout the stress protocol and monitored continuously for a minimum of 5 min post exercise. Heart rate and blood pressure were recorded in each stage of exercise. 40 Patients were evaluated for the change in total exercise treadmill time at 6 months and change in heart rate from peak exercise to one and 5 min post exercise was assessed as an index of autonomic function and predictor of cardiovascular outcome as previously applied in the general population.
41,42
Monitoring physical activity
The International Physical Activity Questionnaire (IPAQ) 43, 44 was administered by a research assistant to document leisure, moderate and vigorous activity which summarizes all the types of physical activity to yield a score, reported as MET minutes per week. MET minutes per week were calculated in subscales of walking, moderate intensity, and vigorous intensity as the product of MET level, minutes per episode, and time spent per week. The total MET minutes per week was the sum of the three subscales, which represented to total amount of physical activity.
Statistical analysis
Data analysis was performed with SAS version 9.3. Chi-square test, Cochran-Armitage trend test and t-tests were used to examine baseline equivalence in demographic and clinical variables between two groups. The change of cardiac outcomes physical activity were estimated using a general linear model (GLM) and least square means (LS-mean) were estimated after controlling for age and baseline outcome. To examine the improvements in metabolic risk factors, the changed scores at 6 and 12 months from baseline between two groups were estimated using mixed effect model with a within-subject correlation structure. LS-means of change score were estimated from group-time interaction term after controlling for age, baseline BMI, and baseline score.
Results
From 1264 potential subjects identified from the tumor registries and 81 referrals, 672 were screened, and of those, 308 were determined eligible, and 154 (76 in the fitness center and 78 in the home-based group) women were enrolled. 35 There were four women who never started the exercise program, and over the first Table 1 Baseline comparisons between fitness center and home based groups.
Fitness center N ¼ 76
Home-based N ¼ 78 six months, four who were lost to follow-up and seven withdrew for non-study injuries or illness conditions leaving 139 women (67 in gym exercise vs. 72 in home-based activity) evaluable (Fig. 1) . The sample consisted of primarily White women (85.7%) who were married (70%), employed either full or part time (82.8%), had a breast cancer diagnosis (83.1%) and an average age of 51.9 years (SD ¼ 6.1). Half of the subjects had received adjuvant chemotherapy (52.7%) and 69.4% were on adjuvant endocrine therapy with either tamoxifen or an aromatase inhibitor. 35 Comparison of baseline characteristics for cardiac, body composition, physical activity level and metabolic risk factors between the fitness center intervention and home based group are shown in Table 1 . Lower triglycerides (p ¼ .0129) and higher peak heart rate (p ¼ .0187) in exercise intervention subjects compared to home-based physical activity subjects were observed at baseline. None of the other baseline characteristics were significantly different between the two groups.
Cardiovascular fitness
Cardiovascular fitness outcomes improved in the fitness center exercise intervention group compared to the home based physical activity group. Both groups improved time on treadmill at 6 months (<.001) (Fig. 2) but the fitness center group had significantly greater improvement (P ¼ .039).
We evaluated change from peak heart rate to 1 min post exercise an established index of autonomic function and cardiovascular fitness. After controlling for peak heart rate and age at baseline, the fitness center group had significantly improved heart rate recovery (HRR) at 1 min compared to the home based group (p ¼ .028) ( Table 2) .
HRR during a cool-down period of 5 min after peak exercise was positively associated with time on treadmill (r ¼ .225, p ¼ .006). There were no significant differences in blood pressure between groups. Significantly greater improvement in total MET minutes per week was observed in the fitness center group compared to the home based group (p < .0001).
Metabolic risk factors
After controlling for age, baseline BMI, and baseline values, Table 3 shows the least square mean and 95% confidence interval of changed metabolic outcomes from baseline. There was a trend for improved insulin resistance in the fitness center intervention group at 6 months (p ¼ .067) and insulin was significantly increased in the home-based group compared to no change in the fitness center group at 12 months (p ¼ .0450).
When cholesterol levels were analyzed by type of adjuvant endocrine therapy (30% aromatase inhibitor [AI], 31% tamoxifen, 39% no endocrine therapy) (Table 4) , women on AI therapy had increased cholesterol levels over time. Those in the home-based group had a statistically significant greater increase compared to the exercise group (p ¼ .0378). Among women on tamoxifen, the home-based group had significantly higher insulin resistance (p ¼ .0486) compared to the fitness center group (Table 4) .
Baseline BMI was an important predictor of increased insulin (p ¼ .0020), insulin resistance (p ¼ .0188), and LDL cholesterol (p ¼ .0469). As weight is also a known factor in metabolic outcomes, weight was categorized as a loss (!5 lbs), stable (within AE 5 lbs) or gain (!5lbs). Of 130 evaluable subjects with weight data at baseline and 12 months, 20% lost weight, 30% gained and 50% were weight stable. There was no change in weight by fitness center or home based group (data not shown) but women who gained weight had significantly higher insulin (p ¼ .0434), and insulin resistance (p ¼ .0194), with no significant changes in other metabolic variables after controlling for age, baseline BMI, and baseline score (Table 5) .
In summary, cardiac autonomic function as reflected by post exercise HRR was significantly improved for subjects in the fitness center intervention compared to the home based group. The aerobic-resistance fitness center intervention also stabilized insulin and insulin resistance for women on AI and Tamoxifen endocrine therapies compared to the observed increases for subjects in the Note. Delta is the changed score during 6 months from baseline and least-square means (LS-Mean) were estimated from general linear regression model after controlling for baseline score and age.
home based group. Baseline BMI was a predictor of increased insulin and insulin resistance and subjects who gained weight during the year of the study also had significant increases in insulin and insulin resistance.
Discussion
The findings of the Yale FIT study confirm the importance of exercise in a high risk cancer survivor population related to cardiovascular outcomes. Both time on treadmill and HRR were significantly improved for subjects in the Yale FIT aerobicresistance intervention group. Improvement in HRR is clinically important as it is a prognostic predictor, 41, 45 an indicator of cardiac autonomic function 46 and overall cardiovascular fitness has been reported to reduce cancer mortality, independent of adiposity. 47 As two-thirds of the subjects in Yale FIT were over- perhaps longer sustained exercise is needed to alter these metabolic outcomes. Weight did influence insulin and insulin resistance with women with stable weight or who lost weight having significantly lower levels, which is similar to a recently published weight loss trial in breast cancer survivors. 57 There was no significant change in triglycerides by group or type of adjuvant therapy. The effect of AI and Tamoxifen endocrine therapy on lipids is mixed 58 and it is unknown even if there are favorable changes in lipids, if that translates into a clinical Note. Least square mean (LS-mean) and 95% confidence intervals were estimated after controlling for age, baseline BMI, and baseline score. ( ǂ) triglyceride was log-transformed to hold a normal assumption of residuals. Table 4 Least square mean of changed metabolic outcomes at 6 and 12 months between the fitness center and home-based groups by adjuvant endocrine therapy type. Note. Least square mean (LS-mean) and 95% confidence intervals were estimated after controlling for age, baseline BMI, and baseline score.
benefit. 59 However, endocrine therapy is now recommended for up to 10 years and the cardiovascular effects are yet to be fully identified. BMI has been reported to be a predictor of increased cardiovascular disease 8 and increased recurrence rate and decreased survival. 16, 48, 51 In Yale FIT, long term cancer outcomes could not be evaluated but baseline BMI was a predictor of increased insulin and insulin resistance. The relationship of BMI and insulin on breast cancer progression is complex 60,61 but a comprehensive risk reduction approach related to cardiovascular disease, diabetes, cancer specific and all-cause mortality is needed. 61 The effect of weight reduction for women who are overweight or obese at diagnosis on disease free and overall survival is unknown as we await results of ongoing trials. 60 However, what is known are the health benefits of regular sustained exercise as a nonpharmacologic intervention for cardiovascular and overall health of women who are cancer survivors. 14, 17, 18 The combination of aerobic plus resistance exercise is recommended for all women >50 years of age and resistance exercise has the potential to decrease chronic illness risks associated with central adiposity, increased fat mass, and elevated waist circumference in normal, overweight and obese breast cancer survivors. 62, 63 Limitations of the study are the sample size, especially for the sub-analyses by type of adjuvant endocrine therapy, the lack of a cardiovascular assessment at 12 months and the downward drift in level of physical activity in the intervention group during the last nonsupervised 6 months. Also, the average age of the subjects was relatively young across the age spectrum of women with cancer and perhaps the intervention would have greater impact on older age survivors with known cardiovascular risk factors. 7, 8 In summary, we demonstrated that a 12-month aerobicresistance exercise intervention delivered at a fitness center resulted in significantly better cardiovascular fitness and metabolic risk factors compared to a national guideline home-based physical activity group. We had a 77.4% adherence rate to the supervised thrice weekly exercise intervention at the fitness centers across the first 6 months. 35 However, based on the MET minutes/week, there was a decline in physical activity in the last six months when women were not being supervised and there was little change in physical activity among the home-based group. A major challenge is how to motivate, engage and sustain cancer survivors in physical activity to achieve a risk reduction benefit. Text messaging, feedback with accelerometers and peer coaching offer potential strategies to promote adherence over time. Innovative and cost effective interventions are needed to increase physical activity and prevent weight gain in order to decrease co-morbid health risks. Note. Least square mean (LS-mean) and 95% confidence intervals were estimated after controlling for age, baseline BMI, and baseline score.
